Market Access News | pharmaphorum

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J manufacturing delays hit US vaccine rollout

The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available.

News

Goofy lama pulling face. Funny llama animal sticking tongue out

ExeVir ready for clinic with variant-targeting llama antibod...

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment

News

Talking vaccines: Industry’s role in protecting the Gavi generation

Austrian safety officials suspend batch of AZ vaccines after...

Austrian health officials have withdrawn a batch of Oxford University/AstraZeneca’s COVID-19 vaccine after two cases of severe coagulation, one of which was fatal.

News

NICE says NHS should fund Novartis' £1.79m SMA gene therapy

The NHS should pay for Novartis’ £1.79 million one-off gene therapy for Spinal Muscular Atrophy (SMA) NICE has said, the most expensive treatment ever approved for funding.

News

scientifically visualization of a coronavirus spike protein

EMA backs emergency use of Lilly’s COVID antibodies

The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 who are at risk of developing severe disease, clearing the way for use in EU memb

News

NICE says no to AZ’s Lynparza for prostate cancer

NHS patients in England will not be able to get access to AstraZeneca’s PARP inhibitor Lynparza if they have BRCA-positive advance prostate cancer, according to draft guidance from NICE.

J&J manufacturing delays hit US vaccine rollout

ExeVir ready for clinic with variant-targeting llama antibod...

Austrian safety officials suspend batch of AZ vaccines after...

NICE says NHS should fund Novartis' £1.79m SMA gene therapy

EMA backs emergency use of Lilly’s COVID antibodies

NICE says no to AZ’s Lynparza for prostate cancer

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks